Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Large Cell Neuroendocrine Cancer (LCNEC)”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Testing effectiveness (Phase 2)Looking for participantsNCT05652686
What this trial is testing

Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

Who this might be right for
Small Cell Lung Cancer (SCLC)Large Cell Neuroendocrine Cancer (LCNEC)Neuroendocrine Prostate Cancer (NEPC)+3 more
Phanes Therapeutics 203
Testing effectiveness (Phase 2)Looking for participantsNCT07278479
What this trial is testing

Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors

Who this might be right for
Large Cell Neuroendocrine CarcinomaLarge Cell Pulmonary Neuroendocrine Carcinoma of the Lung (LCNEC)Extrapulmonary Neuroendocrine Carcinoma (EP-NEC)+4 more
Molecular Partners AG 138
Early research (Phase 1)Study completedNCT06049966
What this trial is testing

Atezolizumab in Large Cell Neuroendocrine Carcinoma

Who this might be right for
Large Cell Neuroendocrine Carcinoma of the Lung
Oncology Center of Biochemical Education And Research 22
Not applicableLooking for participantsNCT06717243
What this trial is testing

Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)

Who this might be right for
Small Cell Lung CancerLarge Cell Neuroendocrine (NE) TumorsTreatment Failure+3 more
Oncology Center of Biochemical Education And Research 111
Early research (Phase 1)Looking for participantsNCT06736418
What this trial is testing

Study of 225Ac-ABD147 to Establish Optimal Dose in Patients With SCLC and LCNEC of the Lung That Previously Received Platinum-based Chemotherapy

Who this might be right for
Small-Cell Lung Cancer (SCLC)Large Cell Neuroendocrine Carcinoma of the Lung
Abdera Therapeutics Inc. 65
Early research (Phase 1)Looking for participantsNCT07006727
What this trial is testing

Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors

Who this might be right for
Small Cell Lung CarcinomaLarge Cell Neuroendocrine Carcinoma of the LungNeuroendocrine Prostate Cancer+1 more
Novartis Pharmaceuticals 116
Testing effectiveness (Phase 2)Active Not RecruitingNCT05470595
What this trial is testing

A Single-arm Trial of Atezolizumab/Platinum/Etoposide for the Treatment of Advanced Large-cell Neuroendocrine Cancer of the Lung

Who this might be right for
Large Cell Neuroendocrine Carcinoma of the Lung
Technische Universität Dresden 67
Early research (Phase 1)Looking for participantsNCT06424665
What this trial is testing

FZ-AD005 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor, SCLC(Small Cell Lung Cancer) or LCNEC (Large Cell Neuroendocrine Carcinoma)
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. 162
Testing effectiveness (Phase 2)Looking for participantsNCT06418087
What this trial is testing

Durvalumab With Carboplatin and Etoposide Chemotherapy in Pulmonary Large-cell Neuroendocrine Carcinoma (LCNEC)

Who this might be right for
Pulmonary Large-cell Neuroendocrine Carcinoma
Gruppo Oncologico Italiano di Ricerca Clinica 49
Not applicableStudy completedNCT03998332
What this trial is testing

Overall Survival of Large Cell Neuroendocrine Lung Cancer Patients - a Retrospective Study

Who this might be right for
Survival Outcomes of Patients With Pulmonary LCNEC
Jaroslaw B. Cwikla, MD, PhD, Professor UWM 132